134 related articles for article (PubMed ID: 8590945)
1. Thyrotropin receptor mutations in hyperfunctioning thyroid adenomas: new mutants, new second messenger and new frequency.
Bertherat J
Eur J Endocrinol; 1996 Jan; 134(1):114. PubMed ID: 8590945
[No Abstract] [Full Text] [Related]
2. Thyrotropin receptor mutations and thyroid hyperfunctioning adenomas ten years after their first discovery: unresolved questions.
Arturi F; Scarpelli D; Coco A; Sacco R; Bruno R; Filetti S; Russo D
Thyroid; 2003 Apr; 13(4):341-3. PubMed ID: 12804102
[TBL] [Abstract][Full Text] [Related]
3. Thyrotropin receptor gene alterations in thyroid hyperfunctioning adenomas.
Russo D; Arturi F; Suarez HG; Schlumberger M; Du Villard JA; Crocetti U; Filetti S
J Clin Endocrinol Metab; 1996 Apr; 81(4):1548-51. PubMed ID: 8636365
[TBL] [Abstract][Full Text] [Related]
4. Hyperfunctioning thyroid nodules in toxic multinodular goiter share activating thyrotropin receptor mutations with solitary toxic adenoma.
Tonacchera M; Chiovato L; Pinchera A; Agretti P; Fiore E; Cetani F; Rocchi R; Viacava P; Miccoli P; Vitti P
J Clin Endocrinol Metab; 1998 Feb; 83(2):492-8. PubMed ID: 9467563
[TBL] [Abstract][Full Text] [Related]
5. Functioning and nonfunctioning thyroid adenomas involve different molecular pathogenetic mechanisms.
Tonacchera M; Vitti P; Agretti P; Ceccarini G; Perri A; Cavaliere R; Mazzi B; Naccarato AG; Viacava P; Miccoli P; Pinchera A; Chiovato L
J Clin Endocrinol Metab; 1999 Nov; 84(11):4155-8. PubMed ID: 10566665
[TBL] [Abstract][Full Text] [Related]
6. Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas.
Parma J; Duprez L; Van Sande J; Cochaux P; Gervy C; Mockel J; Dumont J; Vassart G
Nature; 1993 Oct; 365(6447):649-51. PubMed ID: 8413627
[TBL] [Abstract][Full Text] [Related]
7. Identification and functional characterization of two new somatic mutations causing constitutive activation of the thyrotropin receptor in hyperfunctioning autonomous adenomas of the thyroid.
Paschke R; Tonacchera M; Van Sande J; Parma J; Vassart G
J Clin Endocrinol Metab; 1994 Dec; 79(6):1785-9. PubMed ID: 7989485
[TBL] [Abstract][Full Text] [Related]
8. The thyrotropin receptor in thyroid diseases.
Paschke R; Ludgate M
N Engl J Med; 1997 Dec; 337(23):1675-81. PubMed ID: 9385128
[No Abstract] [Full Text] [Related]
9. Somatic mutations in the VI transmembrane segment of the thyrotropin receptor constitutively activate cAMP signalling in thyroid hyperfunctioning adenomas.
Porcellini A; Ciullo I; Pannain S; Fenzi G; Avvedimento E
Oncogene; 1995 Sep; 11(6):1089-93. PubMed ID: 7566968
[TBL] [Abstract][Full Text] [Related]
10. Genetic alterations in thyroid hyperfunctioning adenomas.
Russo D; Arturi F; Wicker R; Chazenbalk GD; Schlumberger M; DuVillard JA; Caillou B; Monier R; Rapoport B; Filetti S
J Clin Endocrinol Metab; 1995 Apr; 80(4):1347-51. PubMed ID: 7714109
[TBL] [Abstract][Full Text] [Related]
11. New pathophysiological mechanisms for hyperthyroidism.
Vassart G
Horm Res; 1997; 48 Suppl 4():47-50. PubMed ID: 9350447
[TBL] [Abstract][Full Text] [Related]
12. Novel mutations of thyrotropin receptor gene in thyroid hyperfunctioning adenomas. Rapid identification by fine needle aspiration biopsy.
Porcellini A; Ciullo I; Laviola L; Amabile G; Fenzi G; Avvedimento VE
J Clin Endocrinol Metab; 1994 Aug; 79(2):657-61. PubMed ID: 8045989
[TBL] [Abstract][Full Text] [Related]
13. [Non-autoimmune hyperthyroidism and hyperfunctioning thyroid adenomas caused by activating mutation of the thyrotropin receptor].
Kosugi S
Nihon Rinsho; 2002 Feb; 60(2):291-6. PubMed ID: 11857916
[TBL] [Abstract][Full Text] [Related]
14. Enhanced functional activity in thyroid adenomas in vitro.
Poertl S; Kirner J; Mann K; Hoermann R
Exp Clin Endocrinol Diabetes; 1996; 104 Suppl 4():39-40. PubMed ID: 8980999
[TBL] [Abstract][Full Text] [Related]
15. Gs alpha mutations in hyperfunctioning thyroid adenomas.
Murakami M; Kamiya Y; Yanagita Y; Mori M
Arch Med Res; 1999; 30(6):514-21. PubMed ID: 10714366
[TBL] [Abstract][Full Text] [Related]
16. Hyperfunctioning thyroid adenoma and activating mutations in the TSH receptor gene.
Polak M
Arch Med Res; 1999; 30(6):510-3. PubMed ID: 10714365
[TBL] [Abstract][Full Text] [Related]
17. Thyrotropin receptor mutations in hyperfunctioning thyroid adenomas from Brazil.
Nogueira CR; Kopp P; Arseven OK; Santos CL; Jameson JL; Medeiros-Neto G
Thyroid; 1999 Nov; 9(11):1063-8. PubMed ID: 10595453
[TBL] [Abstract][Full Text] [Related]
18. [Activating mutations of the TSH receptor: a synthesis highlighting certain pediatric aspects].
Polak M
Arch Pediatr; 1998; 5 Suppl 4():375S-379S. PubMed ID: 9853087
[TBL] [Abstract][Full Text] [Related]
19. Somatic mutations causing constitutive activity of the thyrotropin receptor are the major cause of hyperfunctioning thyroid adenomas: identification of additional mutations activating both the cyclic adenosine 3',5'-monophosphate and inositol phosphate-Ca2+ cascades.
Parma J; Van Sande J; Swillens S; Tonacchera M; Dumont J; Vassart G
Mol Endocrinol; 1995 Jun; 9(6):725-33. PubMed ID: 8592518
[TBL] [Abstract][Full Text] [Related]
20. Activation of the cAMP cascade in thyroid autonomy.
Paschke R
Exp Clin Endocrinol Diabetes; 1998; 106 Suppl 4():S4-5. PubMed ID: 9867187
[No Abstract] [Full Text] [Related]
[Next] [New Search]
